Global Parkinson's Disease Treatments Market Study Report 2022 Historical Trends, Growth, and Forecast to 2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Parkinson's Disease Treatments market report explains the definition, types, applications, major countries, and major players of the Parkinson's Disease Treatments market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.

    The report contains qualitative and quantitative analysis of the entire industry.

    The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.

    By Player:

    • Abbvie

    • Sun Pharma

    • Boehringer Ingelheim

    • Merck

    • Impax

    • Lundbeck

    • Teva

    • Valeant Pharmaceuticals

    • UCB

    • Novartis

    • Acadia

    • GSK

    • Wockhardt

    By Type:

    • Dopamine Agonists

    • Levodopa

    • Glutamate Antagonist

    • Apomorphine

    • COMT Inhibitors Anticholinergics

    • MAO-B Inhibitors

    • Other Drugs

    By End-User:

    • Hospitals

    • Healthcare Institutes

    • Others

    By Region:

    North America

    • United States

    • Canada

    • Mexico

    Europe

    • Germany

    • UK

    • Spain

    • France

    • Italy

    • Denmark

    • Finland

    • Norway

    • Sweden

    • Poland

    • Russia

    • Turkey

    Asia-Pacific

    • China

    • Japan

    • India

    • South Korea

    • Pakistan

    • Bangladesh

    • Indonesia

    • Thailand

    • Singapore

    • Malaysia

    • Philippines

    • Vietnam

    • Others

    South America

    • Brazil

    • Colombia

    • Chile

    • Argentina

    • Venezuela

    • Peru

    • Puerto Rico

    • Ecuador

    • Others

    GCC

    • Bahrain

    • Kuwait

    • Oman

    • Qatar

    • Saudi Arabia

    • United Arab Emirates

    Africa

    • Nigeria

    • South Africa

    • Egypt

    • Algeriat

    • Others

    Oceania

    • Australia

    • New Zealand

  • TABLE OF CONTENT

    1. Global Parkinson's Disease Treatments Executive Summary

    • 1.1 Introduction

    • 1.2 Market Panorama, 2022

    2 Coronavirus Impact

    • 2.1 Parkinson's Disease Treatments Outlook to 2028- Original Forecasts

    • 2.2 Parkinson's Disease Treatments Outlook to 2028- COVID-19 Affected Forecasts

    • 2.3 Impact on Industry

    3 Strategic Analytics to Boost Productivity and Profitability

    • 3.1 Potential Market Drivers and Opportunities

    • 3.2 New Challenges and Strategies

    • 3.3 Short Term and Long Term Parkinson's Disease Treatments Market Trends

    4 Key Inferences

    5 Market Overview

    • 5.1 Current Market Scenario

    • 5.2 Porter's Five Forces Analysis

      • 5.2.1 Bargaining Power of Suppliers

      • 5.2.2 Bargaining Power of Consumers

      • 5.2.3 Threat of New Entrants

      • 5.2.4 Threat of Substitute Product and Services

      • 5.2.5 Competitive Rivalry within the Industry

    6 Global Parkinson's Disease Treatments Market- Recent Developments

    • 6.1 Parkinson's Disease Treatments Market News and Developments

    • 6.2 Parkinson's Disease Treatments Market Deals Landscape

    7 Parkinson's Disease Treatments Raw Materials and Cost Structure Analysis

    • 7.1 Parkinson's Disease Treatments Key Raw Materials

    • 7.2 Parkinson's Disease Treatments Price Trend of Key Raw Materials

    • 7.3 Parkinson's Disease Treatments Key Suppliers of Raw Materials

    • 7.4 Parkinson's Disease Treatments Market Concentration Rate of Raw Materials

    • 7.5 Parkinson's Disease Treatments Cost Structure Analysis

      • 7.5.1 Parkinson's Disease Treatments Raw Materials Analysis

      • 7.5.2 Parkinson's Disease Treatments Labor Cost Analysis

      • 7.5.3 Parkinson's Disease Treatments Manufacturing Expenses Analysis

    8 Global Parkinson's Disease Treatments Import and Export Analysis (Top 10 Countries)

    • 8.1 Global Parkinson's Disease Treatments Import by Region (Top 10 Countries) (2017-2028)

    • 8.2 Global Parkinson's Disease Treatments Export by Region (Top 10 Countries) (2017-2028)

    9 Global Parkinson's Disease Treatments Market Outlook by Types and Applications to 2022

    • 9.1 Global Parkinson's Disease Treatments Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global Dopamine Agonists Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Levodopa Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Glutamate Antagonist Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global Apomorphine Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global COMT Inhibitors Anticholinergics Consumption and Growth Rate (2017-2022)

      • 9.1.6 Global MAO-B Inhibitors Consumption and Growth Rate (2017-2022)

      • 9.1.7 Global Other Drugs Consumption and Growth Rate (2017-2022)

    • 9.2 Global Parkinson's Disease Treatments Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Healthcare Institutes Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Others Consumption and Growth Rate (2017-2022)

    10 Region and Country-wise Parkinson's Disease Treatments Market Analysis and Outlook till 2022

    • 10.1 Global Parkinson's Disease Treatments Consumption (2017-2022)

    • 10.2 North America Consumption Analysis

      • 10.2.1 United States Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.2.2 Canada Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.2.3 Mexico Parkinson's Disease Treatments Consumption (2017-2022)

    • 10.3 Europe Consumption Analysis

      • 10.3.1 Germany Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.2 UK Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.3 Spain Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.4 Belgium Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.5 France Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.6 Italy Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.7 Denmark Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.8 Finland Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.9 Norway Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.10 Sweden Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.11 Poland Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.12 Russia Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.3.13 Turkey Parkinson's Disease Treatments Consumption (2017-2022)

    • 10.4 APAC Consumption Analysis

      • 10.4.1 China Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.2 Japan Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.3 India Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.4 South Korea Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.5 Pakistan Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.6 Bangladesh Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.7 Indonesia Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.8 Thailand Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.9 Singapore Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.10 Malaysia Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.11 Philippines Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.4.12 Vietnam Parkinson's Disease Treatments Consumption (2017-2022)

    • 10.5 South America Consumption Analysis

      • 10.5.1 Brazil Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.5.2 Colombia Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.5.3 Chile Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.5.4 Argentina Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.5.5 Venezuela Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.5.6 Peru Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.5.7 Puerto Rico Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.5.8 Ecuador Parkinson's Disease Treatments Consumption (2017-2022)

    • 10.6 GCC Consumption Analysis

      • 10.6.1 Bahrain Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.6.2 Kuwait Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.6.3 Oman Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.6.4 Qatar Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.6.5 Saudi Arabia Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.6.6 United Arab Emirates Parkinson's Disease Treatments Consumption (2017-2022)

    • 10.7 Africa Consumption Analysis

      • 10.7.1 Nigeria Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.7.2 South Africa Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.7.3 Egypt Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.7.4 Algeria Parkinson's Disease Treatments Consumption (2017-2022)

    • 10.8 Oceania Consumption Analysis

      • 10.8.1 Australia Parkinson's Disease Treatments Consumption (2017-2022)

      • 10.8.2 New Zealand Parkinson's Disease Treatments Consumption (2017-2022)

    11 Global Parkinson's Disease Treatments Competitive Analysis

    • 11.1 Abbvie

      • 11.1.1 Abbvie Company Details

      • 11.1.2 Abbvie Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.1.3 Abbvie Parkinson's Disease Treatments Main Business and Markets Served

      • 11.1.4 Abbvie Parkinson's Disease Treatments Product Portfolio

      • 11.1.5 Recent Research and Development Strategies

    • 11.2 Sun Pharma

      • 11.2.1 Sun Pharma Company Details

      • 11.2.2 Sun Pharma Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.2.3 Sun Pharma Parkinson's Disease Treatments Main Business and Markets Served

      • 11.2.4 Sun Pharma Parkinson's Disease Treatments Product Portfolio

      • 11.2.5 Recent Research and Development Strategies

    • 11.3 Boehringer Ingelheim

      • 11.3.1 Boehringer Ingelheim Company Details

      • 11.3.2 Boehringer Ingelheim Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.3.3 Boehringer Ingelheim Parkinson's Disease Treatments Main Business and Markets Served

      • 11.3.4 Boehringer Ingelheim Parkinson's Disease Treatments Product Portfolio

      • 11.3.5 Recent Research and Development Strategies

    • 11.4 Merck

      • 11.4.1 Merck Company Details

      • 11.4.2 Merck Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.4.3 Merck Parkinson's Disease Treatments Main Business and Markets Served

      • 11.4.4 Merck Parkinson's Disease Treatments Product Portfolio

      • 11.4.5 Recent Research and Development Strategies

    • 11.5 Impax

      • 11.5.1 Impax Company Details

      • 11.5.2 Impax Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.5.3 Impax Parkinson's Disease Treatments Main Business and Markets Served

      • 11.5.4 Impax Parkinson's Disease Treatments Product Portfolio

      • 11.5.5 Recent Research and Development Strategies

    • 11.6 Lundbeck

      • 11.6.1 Lundbeck Company Details

      • 11.6.2 Lundbeck Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.6.3 Lundbeck Parkinson's Disease Treatments Main Business and Markets Served

      • 11.6.4 Lundbeck Parkinson's Disease Treatments Product Portfolio

      • 11.6.5 Recent Research and Development Strategies

    • 11.7 Teva

      • 11.7.1 Teva Company Details

      • 11.7.2 Teva Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.7.3 Teva Parkinson's Disease Treatments Main Business and Markets Served

      • 11.7.4 Teva Parkinson's Disease Treatments Product Portfolio

      • 11.7.5 Recent Research and Development Strategies

    • 11.8 Valeant Pharmaceuticals

      • 11.8.1 Valeant Pharmaceuticals Company Details

      • 11.8.2 Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.8.3 Valeant Pharmaceuticals Parkinson's Disease Treatments Main Business and Markets Served

      • 11.8.4 Valeant Pharmaceuticals Parkinson's Disease Treatments Product Portfolio

      • 11.8.5 Recent Research and Development Strategies

    • 11.9 UCB

      • 11.9.1 UCB Company Details

      • 11.9.2 UCB Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.9.3 UCB Parkinson's Disease Treatments Main Business and Markets Served

      • 11.9.4 UCB Parkinson's Disease Treatments Product Portfolio

      • 11.9.5 Recent Research and Development Strategies

    • 11.10 Novartis

      • 11.10.1 Novartis Company Details

      • 11.10.2 Novartis Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.10.3 Novartis Parkinson's Disease Treatments Main Business and Markets Served

      • 11.10.4 Novartis Parkinson's Disease Treatments Product Portfolio

      • 11.10.5 Recent Research and Development Strategies

    • 11.11 Acadia

      • 11.11.1 Acadia Company Details

      • 11.11.2 Acadia Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.11.3 Acadia Parkinson's Disease Treatments Main Business and Markets Served

      • 11.11.4 Acadia Parkinson's Disease Treatments Product Portfolio

      • 11.11.5 Recent Research and Development Strategies

    • 11.12 GSK

      • 11.12.1 GSK Company Details

      • 11.12.2 GSK Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.12.3 GSK Parkinson's Disease Treatments Main Business and Markets Served

      • 11.12.4 GSK Parkinson's Disease Treatments Product Portfolio

      • 11.12.5 Recent Research and Development Strategies

    • 11.13 Wockhardt

      • 11.13.1 Wockhardt Company Details

      • 11.13.2 Wockhardt Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

      • 11.13.3 Wockhardt Parkinson's Disease Treatments Main Business and Markets Served

      • 11.13.4 Wockhardt Parkinson's Disease Treatments Product Portfolio

      • 11.13.5 Recent Research and Development Strategies

    12 Global Parkinson's Disease Treatments Market Outlook by Types and Applications to 2028

    • 12.1 Global Parkinson's Disease Treatments Consumption Forecast and Growth Rate by Type (2022-2028)

      • 12.1.1 Global Dopamine Agonists Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.2 Global Levodopa Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.3 Global Glutamate Antagonist Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.4 Global Apomorphine Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.5 Global COMT Inhibitors Anticholinergics Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.6 Global MAO-B Inhibitors Consumption Forecast and Growth Rate (2022-2028)

      • 12.1.7 Global Other Drugs Consumption Forecast and Growth Rate (2022-2028)

    • 12.2 Global Parkinson's Disease Treatments Consumption Forecast and Growth Rate by Application (2022-2028)

      • 12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.2 Global Healthcare Institutes Consumption Forecast and Growth Rate (2022-2028)

      • 12.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)

    13 Country-wise Parkinson's Disease Treatments Market Analysis and Outlook to 2028

    • 13.1 Global Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    • 13.2 North America Consumption Analysis

      • 13.2.1 United States Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.2.2 Canada Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.2.3 Mexico Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    • 13.3 Europe Consumption Analysis

      • 13.3.1 Germany Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.2 UK Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.3 Spain Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.4 Belgium Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.5 France Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.6 Italy Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.7 Denmark Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.8 Finland Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.9 Norway Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.10 Sweden Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.11 Poland Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.12 Russia Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.3.13 Turkey Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    • 13.4 APAC Consumption Analysis

      • 13.4.1 China Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.2 Japan Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.3 India Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.4 South Korea Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.5 Pakistan Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.6 Bangladesh Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.7 Indonesia Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.8 Thailand Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.9 Singapore Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.10 Malaysia Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.11 Philippines Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.4.12 Vietnam Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    • 13.5 South America Consumption Analysis

      • 13.5.1 Brazil Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.5.2 Colombia Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.5.3 Chile Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.5.4 Argentina Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.5.5 Venezuela Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.5.6 Peru Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.5.7 Puerto Rico Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.5.8 Ecuador Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    • 13.6 GCC Consumption Analysis

      • 13.6.1 Bahrain Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.6.2 Kuwait Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.6.3 Oman Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.6.4 Qatar Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.6.5 Saudi Arabia Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.6.6 United Arab Emirates Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    • 13.7 Africa Consumption Analysis

      • 13.7.1 Nigeria Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.7.2 South Africa Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.7.3 Egypt Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.7.4 Algeria Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    • 13.8 Oceania Consumption Analysis

      • 13.8.1 Australia Parkinson's Disease Treatments Consumption Forecast (2022-2028)

      • 13.8.2 New Zealand Parkinson's Disease Treatments Consumption Forecast (2022-2028)

    14 Conclusions


    The List of Tables and Figures

    • Table Definition of Parkinson's Disease Treatments

    • Figure of Parkinson's Disease Treatments Picture

    • Table Global Parkinson's Disease Treatments Import by Region (Top 10 Countries) (2017-2028)

    • Table Global Parkinson's Disease Treatments Export by Region (Top 10 Countries) (2017-2028)

    • Figure Global Dopamine Agonists Consumption and Growth Rate (2017-2022)

    • Figure Global Levodopa Consumption and Growth Rate (2017-2022)

    • Figure Global Glutamate Antagonist Consumption and Growth Rate (2017-2022)

    • Figure Global Apomorphine Consumption and Growth Rate (2017-2022)

    • Figure Global COMT Inhibitors Anticholinergics Consumption and Growth Rate (2017-2022)

    • Figure Global MAO-B Inhibitors Consumption and Growth Rate (2017-2022)

    • Figure Global Other Drugs Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Healthcare Institutes Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Table North America Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Figure United States Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Canada Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Mexico Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Table Europe Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Figure Germany Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure UK Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Spain Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Belgium Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure France Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Italy Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Denmark Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Finland Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Norway Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Sweden Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Poland Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Russia Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Turkey Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Table APAC Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Figure China Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Japan Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure India Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure South Korea Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Pakistan Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Bangladesh Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Indonesia Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Thailand Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Singapore Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Malaysia Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Philippines Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Vietnam Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Table South America Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Figure Brazil Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Colombia Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Chile Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Argentina Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Venezuela Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Peru Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Puerto Rico Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Ecuador Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Table GCC Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Figure Bahrain Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Kuwait Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Oman Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Qatar Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Saudi Arabia Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure United Arab Emirates Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Table Africa Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Figure Nigeria Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure South Africa Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Egypt Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure Algeria Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Table Oceania Parkinson's Disease Treatments Consumption by Country (2017-2022)

    • Figure Australia Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Figure New Zealand Parkinson's Disease Treatments Consumption and Growth Rate (2017-2022)

    • Table Abbvie Company Details

    • Table Abbvie Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Abbvie Parkinson's Disease Treatments Main Business and Markets Served

    • Table Abbvie Parkinson's Disease Treatments Product Portfolio

    • Table Sun Pharma Company Details

    • Table Sun Pharma Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Sun Pharma Parkinson's Disease Treatments Main Business and Markets Served

    • Table Sun Pharma Parkinson's Disease Treatments Product Portfolio

    • Table Boehringer Ingelheim Company Details

    • Table Boehringer Ingelheim Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Boehringer Ingelheim Parkinson's Disease Treatments Main Business and Markets Served

    • Table Boehringer Ingelheim Parkinson's Disease Treatments Product Portfolio

    • Table Merck Company Details

    • Table Merck Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Merck Parkinson's Disease Treatments Main Business and Markets Served

    • Table Merck Parkinson's Disease Treatments Product Portfolio

    • Table Impax Company Details

    • Table Impax Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Impax Parkinson's Disease Treatments Main Business and Markets Served

    • Table Impax Parkinson's Disease Treatments Product Portfolio

    • Table Lundbeck Company Details

    • Table Lundbeck Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Lundbeck Parkinson's Disease Treatments Main Business and Markets Served

    • Table Lundbeck Parkinson's Disease Treatments Product Portfolio

    • Table Teva Company Details

    • Table Teva Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Teva Parkinson's Disease Treatments Main Business and Markets Served

    • Table Teva Parkinson's Disease Treatments Product Portfolio

    • Table Valeant Pharmaceuticals Company Details

    • Table Valeant Pharmaceuticals Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Valeant Pharmaceuticals Parkinson's Disease Treatments Main Business and Markets Served

    • Table Valeant Pharmaceuticals Parkinson's Disease Treatments Product Portfolio

    • Table UCB Company Details

    • Table UCB Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table UCB Parkinson's Disease Treatments Main Business and Markets Served

    • Table UCB Parkinson's Disease Treatments Product Portfolio

    • Table Novartis Company Details

    • Table Novartis Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis Parkinson's Disease Treatments Main Business and Markets Served

    • Table Novartis Parkinson's Disease Treatments Product Portfolio

    • Table Acadia Company Details

    • Table Acadia Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Acadia Parkinson's Disease Treatments Main Business and Markets Served

    • Table Acadia Parkinson's Disease Treatments Product Portfolio

    • Table GSK Company Details

    • Table GSK Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table GSK Parkinson's Disease Treatments Main Business and Markets Served

    • Table GSK Parkinson's Disease Treatments Product Portfolio

    • Table Wockhardt Company Details

    • Table Wockhardt Parkinson's Disease Treatments Sales, Price, Value and Gross Profit (2017-2022)

    • Table Wockhardt Parkinson's Disease Treatments Main Business and Markets Served

    • Table Wockhardt Parkinson's Disease Treatments Product Portfolio

    • Figure Global Dopamine Agonists Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Levodopa Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Glutamate Antagonist Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Apomorphine Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global COMT Inhibitors Anticholinergics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global MAO-B Inhibitors Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Drugs Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Healthcare Institutes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Table North America Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Figure United States Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Canada Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Mexico Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Figure Germany Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure UK Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Spain Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Belgium Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure France Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Italy Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Denmark Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Finland Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Norway Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Sweden Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Poland Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Russia Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Turkey Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Table APAC Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Figure China Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Pakistan Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Bangladesh Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Indonesia Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Thailand Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Singapore Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Malaysia Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Philippines Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Vietnam Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Table South America Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Figure Brazil Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Colombia Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Chile Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Argentina Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Venezuela Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Peru Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Puerto Rico Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Ecuador Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Table GCC Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Figure Bahrain Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Kuwait Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Oman Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Qatar Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Saudi Arabia Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure United Arab Emirates Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Table Africa Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Figure Nigeria Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Africa Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Egypt Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure Algeria Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Table Oceania Parkinson's Disease Treatments Consumption Forecast by Country (2022-2028)

    • Figure Australia Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

    • Figure New Zealand Parkinson's Disease Treatments Consumption Forecast and Growth Rate (2022-2028)

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.